We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$244B
AUM Growth
+$28.7B
Cap. Flow
+$16.9B
Cap. Flow %
6.95%
Top 10 Hldgs %
15.69%
Holding
4,180
New
139
Increased
3,365
Reduced
234
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$465M
2
MSFT icon
Microsoft
MSFT
+$373M
3
AMZN icon
Amazon
AMZN
+$274M
4
XOM icon
ExxonMobil
XOM
+$253M
5
META icon
Meta Platforms (Facebook)
META
+$251M

Sector Composition

Rank Sector Weight
1 Technology 15.77%
2 Financials 15.74%
3 Healthcare 13.31%
4 Industrials 10.5%
5 Consumer Discretionary 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTGN icon
3876
VistaGen Therapeutics
VTGN
$12.8M
$58K ﹤0.01%
1,003
EVFM
3877
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$58K ﹤0.01%
404
+3
+0.7% +$389
PRQR icon
3878
ProQR Therapeutics
PRQR
$265M
$57K ﹤0.01%
11,588
+354
+3% +$1.56K
NEPT
3879
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$57K ﹤0.01%
40
+1
+3% +$1.47K
BIOC
3880
DELISTED
Biocept, Inc.
BIOC
$57K ﹤0.01%
3
DFBG
3881
DELISTED
Differential Brands Group Inc
DFBG
$57K ﹤0.01%
29,479
+348
+1% +$800
SGMA
3882
DELISTED
Sigmatron International
SGMA
$56K ﹤0.01%
11,463
PLXP
3883
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$56K ﹤0.01%
5,431
+29
+0.5% +$315
INSEW
3884
DELISTED
Inspired Entertainment, Inc. Warrants
INSEW
$56K ﹤0.01%
+75,000
New +$48.7K
ASRV icon
3885
AmeriServ Financial
ASRV
$83.5M
$55K ﹤0.01%
14,728
FABC
3886
Fabric.AI Inc
FABC
$18.4M
$55K ﹤0.01%
3
LGMK
3887
DELISTED
LogicMark
LGMK
$55K ﹤0.01%
6
CASI
3888
DELISTED
CASI Pharmaceuticals
CASI
$54K ﹤0.01%
3,870
SEEL
3889
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
AFMD
3890
DELISTED
Affimed
AFMD
$53K ﹤0.01%
2,344
+64
+3% +$1.41K
ATXS
3891
DELISTED
Astria Therapeutics
ATXS
$53K ﹤0.01%
559
+5
+0.9% +$689
PRSO icon
3892
Peraso
PRSO
$11.3M
$53K ﹤0.01%
32
ESES
3893
DELISTED
Eco-Stim Energy Solutions Inc. Common Stock
ESES
$53K ﹤0.01%
45,860
LLEX
3894
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$53K ﹤0.01%
+13,495
New +$56.4K
PZG icon
3895
Paramount Gold Nevada
PZG
$124M
$51K ﹤0.01%
30,702
TENX icon
3896
Tenax Therapeutics
TENX
$503M
$51K ﹤0.01%
3
NBEV
3897
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$51K ﹤0.01%
+12,377
New +$50.2K
RHE
3898
DELISTED
Regional Health Properties, Inc.
RHE
$51K ﹤0.01%
3,380
CNVS icon
3899
Cineverse
CNVS
$65.6M
$50K ﹤0.01%
1,617
+7
+0.4% +$194
UTSI icon
3900
UTStarcom
UTSI
$23.7M
$50K ﹤0.01%
6,336
+138
+2% +$1.01K

Similar funds

Geode Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Geode Capital Management held 4,180 positions worth $244B, up 13% from $215B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geode Capital Management deployed $16.9B of net new capital in Q1 2017, opening 139 new positions and adding to 3,365 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Computer Sciences, an estimated $56.7M trimmed.

  • Geode Capital Management's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 786,074 shares worth $42.8M.
  • Geode Capital Management added most to Apple in Q1 2017, an estimated $465M increase.
  • Geode Capital Management's biggest Q1 2017 reduction was Computer Sciences, cutting an estimated $56.7M.
  • Geode Capital Management fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $249M.
  • Geode Capital Management's ten largest holdings make up 16% of its $244B portfolio in Q1 2017.
  • Geode Capital Management opened 139 new positions and closed 111 in Q1 2017.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $244B.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.